» Articles » PMID: 25497590

Mortality and Cause of Death in a Cohort of People Who Had Ever Injected Drugs in Glasgow: 1982-2012

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2014 Dec 16
PMID 25497590
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To describe all-cause and cause-specific mortality in a cohort of people who had ever injected drugs (PWID) with a low prevalence of HIV over 20-30 years.

Methods: Using a retrospective study design, identifying data from a cohort of PWID recruited between 1982 and 1993 through in-patient drug treatment services were linked to National Records for Scotland deaths data using probabilistic record linkage. We report all-cause and cause-specific mortality rates; standardized mortality ratios (SMR) across time, gender and age were estimated.

Results: Among 456 PWID, 139 (30.5%) died over 9024 person-years (PY) of follow-up. Mortality within the cohort was almost nine times higher than the general population, and remained elevated across all age groups. The greatest excess mortality rate was in the youngest age group, who were 15-24 years of age (SMR 31.6, 95% CI 21.2-47.1). Drug-related deaths declined over time and mortality was significantly higher among HIV positive participants. Although SMRs declined with follow-up, the SMR of the oldest age group (45-60) was 4.5 (95% CI 3.0-6.9). There were no significant differences in all-cause mortality rates between participants who were 25 years and older at cohort entry compared to younger participants.

Conclusion: Mortality rates remained higher than the general population across all age groups. Screening services that identify a history of injecting drug use may be an opportunity to address risk factors faced by an ageing population of PWID and potentially have implications for future health care planning.

Citing Articles

Mortality among HIV-Positive and HIV-Negative People Who Inject Drugs in Mizoram, Northeast India: A Repeated Cross-Sectional Study (2007-2021).

Pachuau L, Tannous C, Chawngthu R, Agho K Int J Environ Res Public Health. 2024; 21(7).

PMID: 39063451 PMC: 11276842. DOI: 10.3390/ijerph21070874.


Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services.

Bartholomew T, Plesons M, Serota D, Alonso E, Metsch L, Feaster D Addict Sci Clin Pract. 2024; 19(1):21.

PMID: 38528570 PMC: 10964520. DOI: 10.1186/s13722-024-00447-9.


"We want everything in a one-stop shop": acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs.

Bartholomew T, Andraka-Cristou B, Totaram R, Harris S, Doblecki-Lewis S, Ostrer L Harm Reduct J. 2022; 19(1):133.

PMID: 36463183 PMC: 9719627. DOI: 10.1186/s12954-022-00721-6.


Adverse childhood experiences and comorbidity in a cohort of people who have injected drugs.

Sosnowski D, Feder K, Astemborski J, Genberg B, Letourneau E, Musci R BMC Public Health. 2022; 22(1):986.

PMID: 35578217 PMC: 9109307. DOI: 10.1186/s12889-022-13369-5.


A cohort study revealed high mortality among people who inject drugs in Hai Phong, Vietnam.

Vinh V, Vallo R, Thi Giang H, Huong D, Oanh K, Khue P J Clin Epidemiol. 2021; 139:38-48.

PMID: 34280476 PMC: 10116693. DOI: 10.1016/j.jclinepi.2021.07.007.